Search

European Commission Approves 320mg Syringes and Pens of UCB’s Bimekizumab

The European Commission (EC) has granted marketing authorization for two 320mg device presentations of UCB’s bimekizumab (Bimzelx, UCB). The pre-filled syringe and pre-filled pen each contain 320 mg of bimekizumab in a volume of 2mL and provide alternatives to the currently available 160 mg in a volume of 1 mL injection options. UCB developed the […]